Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
Pulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients’ survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ig...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/7/2509 |
id |
doaj-db44b00b5f574211b3fd6b6b871e6214 |
---|---|
record_format |
Article |
spelling |
doaj-db44b00b5f574211b3fd6b6b871e62142020-11-25T03:01:16ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-04-01212509250910.3390/ijms21072509Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the AortaJorge Nuche0Julián Palomino-Doza1Fernando Arribas Ynsaurriaga2Juan F. Delgado3Borja Ibáñez4Eduardo Oliver5Pilar Escribano Subías6Centro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainCentro de Investigaciones Biomédicas en Red de enfermedades CardioVasculares (CIBERCV), 28029 Madrid, SpainPulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients’ survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ignored, such as pulmonary artery aneurysm (PAA). The presence of a dilated pulmonary artery has been shown to be related to an increased risk of sudden cardiac death among PAH patients. This increased risk could be associated to the development of left main coronary artery compression or pulmonary artery dissection. Nevertheless, very little is currently known about the molecular mechanisms related to PAA. Thoracic aortic aneurysm (TAA) is a well-known condition with an increased risk of sudden death caused by acute aortic dissection. TAA may be secondary to chronic exposure to classic cardiovascular risk factors. In addition, a number of genetic variants have been shown to be related to a marked risk of TAA and dissection as part of multisystemic syndromes or isolated familial TAA. The molecular pathways implied in the development of TAA have been widely studied and described. Many of these molecular pathways are involved in the pathogenesis of PAH and could be involved in PAA. This review aims to describe all these common pathways to open new research lines that could help lead to a better understanding of the pathophysiology of PAH and PAA and their clinical implications.https://www.mdpi.com/1422-0067/21/7/2509molecular biologygenepulmonary arterial hypertensionpulmonary artery aneurysmaortic aneurysm |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jorge Nuche Julián Palomino-Doza Fernando Arribas Ynsaurriaga Juan F. Delgado Borja Ibáñez Eduardo Oliver Pilar Escribano Subías |
spellingShingle |
Jorge Nuche Julián Palomino-Doza Fernando Arribas Ynsaurriaga Juan F. Delgado Borja Ibáñez Eduardo Oliver Pilar Escribano Subías Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta International Journal of Molecular Sciences molecular biology gene pulmonary arterial hypertension pulmonary artery aneurysm aortic aneurysm |
author_facet |
Jorge Nuche Julián Palomino-Doza Fernando Arribas Ynsaurriaga Juan F. Delgado Borja Ibáñez Eduardo Oliver Pilar Escribano Subías |
author_sort |
Jorge Nuche |
title |
Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta |
title_short |
Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta |
title_full |
Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta |
title_fullStr |
Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta |
title_full_unstemmed |
Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta |
title_sort |
potential molecular pathways related to pulmonary artery aneurysm development: lessons to learn from the aorta |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2020-04-01 |
description |
Pulmonary arterial hypertension (PAH) is a rare disease caused by pulmonary vascular remodeling. Current vasodilator treatments have substantially improved patients’ survival. This improved survival has led to the appearance of complications related to conditions previously underdiagnosed or even ignored, such as pulmonary artery aneurysm (PAA). The presence of a dilated pulmonary artery has been shown to be related to an increased risk of sudden cardiac death among PAH patients. This increased risk could be associated to the development of left main coronary artery compression or pulmonary artery dissection. Nevertheless, very little is currently known about the molecular mechanisms related to PAA. Thoracic aortic aneurysm (TAA) is a well-known condition with an increased risk of sudden death caused by acute aortic dissection. TAA may be secondary to chronic exposure to classic cardiovascular risk factors. In addition, a number of genetic variants have been shown to be related to a marked risk of TAA and dissection as part of multisystemic syndromes or isolated familial TAA. The molecular pathways implied in the development of TAA have been widely studied and described. Many of these molecular pathways are involved in the pathogenesis of PAH and could be involved in PAA. This review aims to describe all these common pathways to open new research lines that could help lead to a better understanding of the pathophysiology of PAH and PAA and their clinical implications. |
topic |
molecular biology gene pulmonary arterial hypertension pulmonary artery aneurysm aortic aneurysm |
url |
https://www.mdpi.com/1422-0067/21/7/2509 |
work_keys_str_mv |
AT jorgenuche potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta AT julianpalominodoza potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta AT fernandoarribasynsaurriaga potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta AT juanfdelgado potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta AT borjaibanez potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta AT eduardooliver potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta AT pilarescribanosubias potentialmolecularpathwaysrelatedtopulmonaryarteryaneurysmdevelopmentlessonstolearnfromtheaorta |
_version_ |
1724693983443025920 |